These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 18703781)
1. Increased sensitivity to local anesthetic drugs: bedside to bench. Fozzard HA Circ Res; 2008 Aug; 103(4):325-7. PubMed ID: 18703781 [No Abstract] [Full Text] [Related]
2. Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel. Barajas-Martínez HM; Hu D; Cordeiro JM; Wu Y; Kovacs RJ; Meltser H; Kui H; Elena B; Brugada R; Antzelevitch C; Dumaine R Circ Res; 2008 Aug; 103(4):396-404. PubMed ID: 18599870 [TBL] [Abstract][Full Text] [Related]
3. [Brugada syndrome, bupivacaine, lidocaine, and techniques to provide local or regional anesthesia: comments on "Ventricular fibrillation in a patient with a type I Brugada syndrome ECG pattern and hypokalemia"]. Sánchez Ortega JL; González Pérez P; Escribano Jiménez M Rev Esp Anestesiol Reanim; 2008 Oct; 55(8):518-20; author reply 520. PubMed ID: 18985869 [No Abstract] [Full Text] [Related]
9. A paradoxical effect of lidocaine for the N406S mutation of SCN5A associated with Brugada syndrome. Itoh H; Tsuji K; Sakaguchi T; Nagaoka I; Oka Y; Nakazawa Y; Yao T; Jo H; Ashihara T; Ito M; Horie M; Imoto K Int J Cardiol; 2007 Oct; 121(3):239-48. PubMed ID: 17445919 [TBL] [Abstract][Full Text] [Related]
13. SCN5A mutations and the role of genetic background in the pathophysiology of Brugada syndrome. Probst V; Wilde AA; Barc J; Sacher F; Babuty D; Mabo P; Mansourati J; Le Scouarnec S; Kyndt F; Le Caignec C; Guicheney P; Gouas L; Albuisson J; Meregalli PG; Le Marec H; Tan HL; Schott JJ Circ Cardiovasc Genet; 2009 Dec; 2(6):552-7. PubMed ID: 20031634 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome. Meregalli PG; Ruijter JM; Hofman N; Bezzina CR; Wilde AA; Tan HL J Cardiovasc Electrophysiol; 2006 Aug; 17(8):857-64. PubMed ID: 16764707 [TBL] [Abstract][Full Text] [Related]
15. A Novel SCN5A Mutation Associated with Drug Induced Brugada Type ECG. Turker I; Makiyama T; Vatta M; Itoh H; Ueyama T; Shimizu A; Ai T; Horie M PLoS One; 2016; 11(8):e0161872. PubMed ID: 27560382 [TBL] [Abstract][Full Text] [Related]
16. [Cardiac sodium channelopathy from bench to bedside]. Zhang YM; Zhou N Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):874-7. PubMed ID: 24484568 [No Abstract] [Full Text] [Related]
18. The occurrence of Brugada syndrome and isolated cardiac conductive disease in the same family could be due to a single SCN5A mutation or to the accidental association of both diseases. Six I; Hermida JS; Huang H; Gouas L; Fressart V; Benammar N; Hainque B; Denjoy I; Chahine M; Guicheney P Europace; 2008 Jan; 10(1):79-85. PubMed ID: 18156160 [TBL] [Abstract][Full Text] [Related]
19. Clinical heterogeneity in sodium channelopathies. What is the meaning of carrying a genetic mutation? Oliva A; Bjerregaard P; Hong K; Evans S; Vernooy K; McCormack J; Brugada J; Brugada P; Pascali VL; Brugada R Cardiology; 2008; 110(2):116-22. PubMed ID: 17971661 [TBL] [Abstract][Full Text] [Related]
20. Structural myocardial abnormalities in asymptomatic family members with Brugada syndrome and SCN5A gene mutation. Frustaci A; Russo MA; Chimenti C Eur Heart J; 2009 Jul; 30(14):1763. PubMed ID: 19411664 [No Abstract] [Full Text] [Related] [Next] [New Search]